Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T14:40:42.783Z.
Consensus retrieved: 2026-10-06T08:39:10.566Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T14:40:42.783Z.
Quote observation: 2026-10-06T14:40:28.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 465112d98a6c82939a581bc37d9e1b887570666ec45509b145499b9afd19c223
Forward PE Ratio (N/A) = Dated Quote Price ($0.94) / Consensus Forward EPS ($-0.34)
FORWARD PE RATIO
N/A
Aldeyra The
Market Cap
$56.71M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Aldeyra The (ALDX) | $56.71M | N/A |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.54M | N/A |
| Boundless Bio, Inc. (BOLD)vs › | $58.66M | N/A |
| Fractyl Health, Inc. (GUTS)vs › | $59.10M | N/A |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.56M | N/A |
| Adicet Bio, Inc. (ACET)vs › | $60.02M | N/A |
| Spectral AI, Inc. (MDAI)vs › | $55.37M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $54.48M | N/A |
| ImageneBio Inc (IMA)vs › | $53.63M | N/A |
| InterCure Ltd. (INCR)vs › | $63.02M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.94, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.34 | $-0.47 – $-0.21 | 3 | n/m |
| 2027-12-31 | $-0.28 | $-0.38 – $-0.17 | 3 | n/m |
| 2028-12-31 | $-0.14 | $-0.27 – $-0.02 | 2 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
